Previous studies showed that PD-L1 was regulated by the phosphoinositide-3-kinase–protein kinase B (PI3K)/protein kinase B (AKT)/mammalian targets of rapamycin (mTOR) pathway, which promoted cancer protein synthesis, survival, proliferation, and apoptosis [16]. Here, MTOR is linked to cancer.